Anti drug antibodies monitoring in biologics use: clinical implications.

CONCLUSION: Recent literature is consistent with the fact that drug monitoring using ADA dosage coupled with residual drug concentration offers reliable options to comfort practitioner' therapeutic management decisions. This is particularly interesting in failure to treatment or in side effects onset situations.
PMID: 32940186 [PubMed - as supplied by publisher]

Source: Current Clinical Pharmacology - September 15, 2020 Category: Drugs & Pharmacology Authors: Dhahri R, Athimni S, Slouma M, Metoui L, Gharsallah I, Louzir B Tags: Curr Clin Pharmacol Source Type: research